1.The Chinese National Workshop on Fatty Liver and Alcoholic Liver Disease ForThe Chinese Liver Disease Association Guidelines for management of nonalcoholic fatty liver disease:an updated and revised edition[].Chinese Journal of Hepatology.2010
2Cheng J,,XiaoL.pplication of silymarin in ehe anei-liver fibrosis[].Guoji Xiaohuabing Zazhi.2007
3Lampe JW.Diet,genetic polymorphisms,detoxification.and health risks[].Altrn Ther Health Med.2007
4Negi AS,,Kumar JK,Luqman S,et al.Recent advances in plant hepatoproteives:a chemical and biological profile of some importanr leads[].Med Res RRev.2008
5Russmann S,Kullak-Ublick GA,Grattagliano I.Current concepts of mechanisms in drug-induced hepatotoxicity[].Current Medicinal Chemistry.2009
3Slotta JE, Justinger C, Kollmar O, et al. Liver injury following blunt abdominal trauma: a new mechanism-driven classification[J]. Surg Today,2014,44:241-246.
4Kelava T, Cavar I. Hepatoprotective action of panaxatriol saponins against acetaminophen-induced liver injury: what is the mechanism?[J]. Liver Int,2014,34:644-645.
5Ma Y, Niu C, Wang J, et al. Diosbulbin B-induced liver injury in mice and its mechanism[J]. Hum Exp Toxicol,2013,33:729-736.
6Ji L, Jiang P, Lu B, et al. Chlorogenic acid, a dietary polyphenol, protects acetaminophen-induced liver injury and its mechanism[J]. J Nutr Biochem,2013,24:191 1- 1919.
7Zahedi K, Barone SL, Xu J, et al. Hepatocyte-specific ablation of spermine/spermidine-Nl-acetyltransferase gene reduces the severity of CCl4-induced acute liver injury[J]. Am J Physiol Gastrointest Liver Physiol,2012,303:556-559.
8Kalegari M, Gemin CA, Araujo-Silva G, et al. Chemical composition, antioxidant activity and hepatoprotective potential of Rourea induta Planch. (Connaraceae) against CCl4-induced liver injury in female rats[J]. Nutrition,2014,30:713-718.
9Jalali GB, Ghaffari H, Prakash HS, et al. Antioxidant and hepatoprotective effects of Solanum xanthocarpum leaf extracts against CCI4-induced liver injury in rats[J]. Pharm Biol,2014,52:1066- 1068.
10Wallace K, Cowie DE, Konstantinou DK, et al. The PXR is a drug target for chronic inflammatory liver disease[J]. J Steroid Biochem Mol Biol,2010,120:137-148.
